Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
19th Bioshares Biotech Summit
Summit History
Contact
Contact Us
Email Alerts
Home
>
Premium Biotech Coverage
>
Current News
Current News
Categories
Categories
Actinogen (ACW)
Adalta (1AD)
Amplia Therapeutics (ATX)
Anteris Technologies (AVR)
Aroa Biosurgery (ARX)
Blinklab (BB1)
Blog
Botanix (BOT)
Chimeric Therapeutics (CHM)
Clever Culture Systems (CC5)
Clinuvel Pharmaceuticals (CUV)
Cogstate (CGS)
Dimerix (DXB)
EBR Systems (EBR)
Immuron (IMC)
Imugene (IMU)
Island Pharmaceuticals (ILA)
Neuren Pharmaceuticals (NEU)
Patrys (PAB)
Syntara (SNT) (previously Pharmaxis, PXS)
Uncategorized
September 19th, 2022
Pharmaxis: Can PXS-6302 'Un-scar the Scar'?
Read More
September 19th, 2022
ResApp Health Sold to Pfizer for $180 Million
Read More
September 19th, 2022
Pharmaxis: Can PXS-6302 'Un-scar the Scar'?
Read More
September 19th, 2022
Imugene to Raise $80 Million
Read More
September 19th, 2022
Cogstate - Investors Await Lecanemab Phase III Data
Read More
September 9th, 2022
Pharmaxis Repurposes PXS-4728 for Parkinson's Disease
Read More
September 9th, 2022
Patrys Passes Final Manufacturing Tests for PAT-DX1
Read More
September 9th, 2022
Anteris Technologies to Present Key Data at TCT this Month
Read More
September 9th, 2022
Patrys Passes Final Manufacturing Tests for PAT-DX1
Read More
August 19th, 2022
Opthea – Novel Funding to Access US$260 Million
Read More
Pages
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
